Trademark: 88242123
Status Date
Tuesday, October 4, 2022
Registration Number
6866593
Registration Date
Tuesday, October 4, 2022
Filing Date
Wednesday, December 26, 2018
Published for Opposition
Tuesday, October 8, 2019
5 pharmaceutical preparations and substances for the treatment of gastrointestinal diseases, metabolic diseases, microbiome-related conditions, neurological diseases and disorders, and diseases and disorders associated with intestinal permeability ; pharmaceutical preparations and substances for treatment of diseases related to the gut-brain axis, gut-brain circuits and gut-restricted and gut-targeted molecules
1 Active chemical ingredients for use in the manufacture of pharmaceuticals for the treatment of gastrointestinal diseases, metabolic diseases, microbiome related conditions, and neurological diseases and disorders, and any disease or disorder associated with intestinal permeability; biochemicals for in vitro and in vivo scientific or research use; ; Active chemical ingredients for scientific or research use in the manufacture of pharmaceuticals for the treatment of gastrointestinal diseases, metabolic diseases, microbiome related conditions, and neurological diseases and disorders, and any disease or disorder associated with intestinal permeability
42 medical and scientific research in the fields of gastrointestinal diseases, metabolic diseases, microbiome-related conditions, neurological diseases and disorders, and diseases and disorders associated with intestinal permeability; scientific and medical research and development; biological research and development; bacteriological research and development; pharmaceutical scientific research and development; pharmaceutical new product research and development for others; scientific chemical, biochemical, biotechnological, biological and bacteriological research and analysis; providing medical and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; medical and scientific research in the fields of diseases of the gut-brain axis, gut-brain circuits and gut-restricted and gut-targeted molecules
Oct 4, 2022
Notice Of Registration Confirmation Emailed
Oct 4, 2022
Registered-Principal Register
Aug 30, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Aug 27, 2022
Allowed Principal Register - Sou Accepted
Jul 29, 2022
Teas/Email Correspondence Entered
Jul 29, 2022
Correspondence Received In Law Office
Jul 29, 2022
Teas Response To Office Action Received
Jun 2, 2022
Teas Extension Received
Feb 1, 2022
Notification Of Non-Final Action E-Mailed
Feb 1, 2022
Non-Final Action E-Mailed
Feb 1, 2022
Su - Non-Final Action - Written
Jan 4, 2022
Statement Of Use Processing Complete
Dec 10, 2021
Use Amendment Filed
Jan 4, 2022
Case Assigned To Intent To Use Paralegal
Dec 10, 2021
Teas Statement Of Use Received
Dec 4, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 2, 2021
Sou Extension 4 Granted
Dec 2, 2021
Sou Extension 4 Filed
Dec 2, 2021
Teas Extension Received
Jun 3, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 1, 2021
Sou Extension 3 Granted
Jun 1, 2021
Sou Extension 3 Filed
Jun 1, 2021
Teas Extension Received
Dec 2, 2020
Notice Of Approval Of Extension Request E-Mailed
Nov 30, 2020
Sou Extension 2 Granted
Nov 30, 2020
Sou Extension 2 Filed
Nov 30, 2020
Teas Extension Received
May 23, 2020
Notice Of Approval Of Extension Request E-Mailed
May 21, 2020
Sou Extension 1 Granted
May 21, 2020
Sou Extension 1 Filed
May 21, 2020
Teas Extension Received
Dec 3, 2019
Noa E-Mailed - Sou Required From Applicant
Oct 8, 2019
Official Gazette Publication Confirmation E-Mailed
Oct 8, 2019
Published For Opposition
Sep 18, 2019
Notification Of Notice Of Publication E-Mailed
Sep 5, 2019
Assigned To Lie
Aug 31, 2019
Approved For Pub - Principal Register
Aug 31, 2019
Teas/Email Correspondence Entered
Aug 30, 2019
Correspondence Received In Law Office
Aug 30, 2019
Teas Response To Office Action Received
Mar 21, 2019
Notification Of Non-Final Action E-Mailed
Mar 21, 2019
Non-Final Action E-Mailed
Mar 21, 2019
Non-Final Action Written
Mar 18, 2019
Assigned To Examiner
Jan 17, 2019
New Application Office Supplied Data Entered In Tram
Dec 29, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
